Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 9, 2002, Pages 4297-4300

  Ehrmann, David A ^a   Tang, Xu ^a   Yoshiuchi, Issei ^a   Cox, Nancy J ^a   Bell, Graeme I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CAUCASIAN; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; OVARY DISEASE; OVARY POLYCYSTIC DISEASE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AMINO ACID SUBSTITUTION; BASE SEQUENCE; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION, MISSENSE; PHENOTYPE; PHOSPHOPROTEINS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; RECEPTOR, INSULIN;

FALLOPIA; PIERINAE;

EID: 0036739962     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020216     Document Type: Article

References (24)

1. Ehrmann D, Barnes R, Rosenfield R 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
2. Polonsky K, Sturis J, Bell G 1996 Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the β cell to compensate for insulin resistance. N Engl J Med 334:777-783
3. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E 2001 Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol 281:E392-E399
4. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R 2001 Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15:2099-2111
5. Burks DJ, White MF 2001 IRS proteins and β-cell function. Diabetes 50(Suppl 1):S140-S145.
6. 1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50:2164-2168
7. 972R polymorphism of IRS-1 in women with polycystic ovary syndrome. Diabetologia 44:1200-1201
8. Witchel SF, Smith R, Tomboc M, Aston CE 2001 Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril 75:724-730
9. Ehrmann D, Rosenfield R, Barnes R, Brigell D, Sheikh Z 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327:157-162
10. Zawadzki J, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens, J, Haseltine F, Merriam G, eds. Current issues in endocrinology and metabolism - polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 377-384.
11. 12Ala polymorphism in the peroxisome proliferator-activated receptor-γ gene. J Clin Endocrinol Metab 87:772-775
12. Ehrmann D, Schwarz P, Hara M, Tang X, Horikawa Y, Imperial J, Bell G, Cox N 2002 Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87:1669-1673
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1997 Diabetes Care 20:1183-1197
14. Morgan C, Lazarow A 1963 Immunoassay of insulin: two antibody systems: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12:115-126
15. Faber O, Binder C, Markussen J, Heding L, Naithani V, Kuzuga H, Blix P, Horwitz D, Rubenstein A 1978 Characterization of seven C-peptide antisera. Diabetes 27:170-177
16. Ehrmann D, Barnes R, Rosenfield R, Cavaghan M, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
17. Legro R, Kunselman A, Dodson W, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
18. Ehrmann D, Sturis J, Byrne M, Karrison T, Rosenfield R, Polonsky K 1995 Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 96:520-527
19. Ehrmann D, Schneider D, Sobel B, Cavaghan M, Imperial J, Rosenfield R, Polonsky K 1997 Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108-2116
20. Bentley-Lewis R, Legro R, Wang S, Driscoll D, Strauss J, Dunaif A, Clustering of insulin resistance and lipoprotein changes in polycystic ovary syndrome (PCOS) families: co-segregation with hyperandrogenemia rather than anovulation. 82nd Annual Meeting of The Endocrine Society, Toronto, Canada, 2000, p 438 (Abstract 1808)
21. Colilla S, Cox NJ, Ehrmann DA 2001 Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 86:2027-2031
22. 1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Hum Mol Genet 9:2517-2521
23. Almind K, Frederiksen SK, Bernal D, Hansen T, Ambye L, Urhammer S, Ekstrom CT, Berglund L, Reneland R, Lithell H, White MF, Van Obberghen E, Pedersen O 1999 Search for variants of the gene-promoter and the potential phosphotyrosine encoding sequence of the insulin receptor substrate-2 gene: evaluation of their relation with alterations in insulin secretion and insulin sensitivity. Diabetologia 42:1244-1249
24. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF 1999 IRS-2 coordinates IGF-1 receptor-mediated β-cell development and peripheral insulin signalling. Nat Genet 23:32-40